ID   LIM2537
AC   CVCL_4441
SY   LIM 2537; LIM-2537
DR   BioSample; SAMN07624438
DR   cancercelllines; CVCL_4441
DR   CBA; CBA-0168
DR   ColonAtlas; LIM2537
DR   Cosmic; 1238057
DR   Cosmic; 1482514
DR   Cosmic; 1486139
DR   Cosmic; 1524338
DR   GEO; GSM1448135
DR   Wikidata; Q54902538
RX   PubMed=11606375;
RX   PubMed=19378335;
RX   PubMed=25926053;
CC   From: Ludwig Institute for Cancer Research, Melbourne Branch; Melbourne; Australia.
CC   Doubling time: 30 hours (CBA=CBA-0168).
CC   Microsatellite instability: Instable (MSI) (PubMed=19378335; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19378335).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=19378335).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CBA=CBA-0168; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 8,13,14 (CBA=CBA-0168)
ST   D13S317: 8,14 (PubMed=25926053)
ST   D16S539: 12
ST   D18S51: 16,17,18,19
ST   D19S433: 12,14
ST   D21S11: 28,29,30
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 8,11
ST   D8S1179: 12,13,14
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C5105; Colorectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 26
//
RX   PubMed=11606375;
RA   Philp A.J., Campbell I.G., Leet C., Vincan E., Rockman S.P.,
RA   Whitehead R.H., Thomas R.J.S., Phillips W.A.;
RT   "The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in
RT   human ovarian and colon tumors.";
RL   Cancer Res. 61:7426-7429(2001).
//
RX   PubMed=19378335; DOI=10.1002/ijc.24289;
RA   Zhang H.-H., Walker F., Kiflemariam S., Whitehead R.H., Williams D.,
RA   Phillips W.A., Mikeska T., Dobrovic A., Burgess A.W.;
RT   "Selective inhibition of proliferation in colorectal carcinoma cell
RT   lines expressing mutant APC or activated B-Raf.";
RL   Int. J. Cancer 125:297-307(2009).
//
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002.1-7002.10(2015).
//